Clinical Trial Update: Leflunomide for Maintenance of Remission in IgG4 Related Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating leflunomide for maintenance of remission in IgG4-related disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin G4 Related Sclerosing Disease

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Immunoglobulin G4 Related Sclerosing Disease | Phase 4 | Status: COMPLETED